ANGPTL2 and achalasia-alacrima syndrome: Previous studies have demonstrated that ANGPTL2 expression is increased in macrophages in tissues of patients with AAAs and that macrophage-derived ANGPTL2 is involved in the development of AAAs via triggering inflammatory responses in the vessel wall and extracellular matrix degradation [20].